In this case, the clinical features of patient with CdLS phenotype correlated with RAD21 gene alterations, while TNFAIP3 modifications were consistent with her history of erythematous, scaly, and pruritic plaques, culminating in erythroderma (Figure 1). Here, TNFAIP3 is linked to exfoliative dermatitis.